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Edited by Veli-Pekka LehtoAbstract The consequences of ultraviolet (UV) exposure are
implicated in skin aging and cell death. The ribosomal protein
S3 (rpS3) is one of the major proteins by which cells counteract
the deleterious eﬀects of UV and it plays a role in the repair of
damaged DNA. In the present study, we investigated the protec-
tive eﬀects of PEP-1-rpS3 fusion protein after UV-induced cell
injury. A human rpS3 gene was fused with PEP-1 peptide in a
bacterial expression vector to produce a genetic in-frame PEP-
1-rpS3 fusion protein. The expressed and puriﬁed fusion proteins
were eﬃciently transduced into skin cells in a time- and dose-
dependent manner. Once inside the cells, transduced PEP-1-
rpS3 fusion protein was stable for 48 h. We showed that
transduced PEP-1-rpS3 fusion protein increased cell viability
and dramatically reduced DNA lesions in the UV exposed skin
cells. Immunohistochemical analysis revealed that PEP-1-rpS3
fusion protein eﬃciently penetrated the epidermis as well as
the dermis of the subcutaneous layer when sprayed on animal
skin. These results suggest that PEP-1-rpS3 fusion protein can
be used in protein therapy for various disorders related to UV,
including skin aging and cancer.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Protein transduction; PEP-1 peptide; Ribosomal
protein S3; Ultraviolet-damage; Protein therapy1. Introduction
Skin is continuously exposed to many hazardous environ-
mental agents, including ultraviolet (UV) light and pro-oxi-
dant air pollutants, such as ozone and ionizing radiation,Abbreviations: rpS3, ribosomal protein S3; UV, ultraviolet; ROS,
reactive oxygen species; PTD, protein transduction domain; PBS,
phosphate-buﬀered saline
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doi:10.1016/j.febslet.2006.11.038which are recognized free radical sources. Reactive oxygen spe-
cies (ROS) are believed to be involved in many inﬂammatory
skin disorders, skin cancer formation, cutaneous autoimmune
diseases, phototoxicity, photosensitivity, and skin aging [1].
ROS are highly reactive and capable of producing a large
array of base modiﬁcations of DNA. These modiﬁcations
could have a role in mutagenesis, carcinogenesis, and aging
[2,3]. The attack that free radicals have on DNA is varied
and profound; single- and double-strand breaks and the pro-
duction of baseless sites in DNA are a common result of free
radical damage to DNA [4]. DNA repair represents a major
pathway in any eﬀort against free radical attack on DNA.
The formation of damage to DNA is subject to repair by the
base excision repair pathway, which is initiated by N-glycosy-
lase that cleaves to the glycosylic bond between the sugar and
the damaged base, resulting in an apurinic/apyrimidinic (AP)
site. Most of the N-glycosylases that act on oxidatively dam-
aged purines and pyrimidines also possess AP lyase activity
[5,6].
Ribosomal protein S3 (rpS3) is one of the components of the
40S ribosomal small subunit of eukaryotic ribosomes that are
cross-linked to the initiation factor eIF2 [7] and eIF3 [8]. As
rpS3 has a nuclear localization of signal in the N-terminal
region, it is believed that the translation functions of rpS3
operate in the cytosol, and the repair function operates in
the nucleus [9]. In addition to their role in ribosomal functions,
many ribosomal proteins have secondary functions in replica-
tion, transcription, RNA processing, DNA repair, and malig-
nant transformation [10].
Ribosomal proteins are in general highly conserved between
human and rat (99%), compared to rat and yeast (60%), rat
and eubacteria (27%), and rat and archaebacteria (34%)
[11,12]. Human rpS3 has an endonuclease activity included
in the repair of UV-damaged DNA. UV-damaged DNA con-
tains cyclobutane pyrimidine dimmers, AP sites and other
lesions such as thymine glycols functioning as a general base-
damage endonuclease [11,13].
Recently, several small regions of proteins, called protein
transduction domains (PTDs), have been developed to allow
the delivery of exogenous protein into living cells. These in-
clude carrier peptides derived from the HIV-1 Tat protein,blished by Elsevier B.V. All rights reserved.
AT7 term  – rpS3  – PEP-1  – His-Tag  – Lac O  – T7 Prom
PEP-1-rpS3
MCS
Apr
ori
lacl
XhoBamH
6756 S.H. Choi et al. / FEBS Letters 580 (2006) 6755–6762Drosophila Antennapedia (Antp) protein, and herpes simplex
virus VP22 protein [14–16]. Up to the present, many research-
ers have demonstrated the successful delivery of full-length Tat
fusion proteins by protein transduction technology [17]. By
using this protein transduction technology, we have reported
that a genetic in-frame Tat-green ﬂuorescent fusion protein
(Tat-GFP), Tat-Cu,Zn superoxide dismutase (Tat-SOD),
Tat-catalase, Tat-pyridoxal kinase (Tat-PK) and Tat-pyrid-
oxal-5 0-P oxidase (Tat-PO) fusion proteins were eﬃciently
transduced into mammalian cells and skin [18–24]. Recently,
we reported that the transduced Tat-SOD signiﬁcantly
protected pancreatic b-cells from oxidative stress-induced
destruction, and consequently improved the diabetic status
of streptozotocin-induced diabetic mice [25] and this fusion
proteins also transduced into neuronal cells across the
blood–brain barrier and prevented neuronal cell death in the
hippocampus caused by transient forebrain ischemia [26].
In the present study, we designed the PEP-1-rpS3 fusion pro-
tein by genetic in-frame for transduction directly in vitro and
in vivo and showed that the PEP-1-rpS3 fusion protein can
be directly transduced into skin cells, and that it can eﬃciently
protect against skin cell death. Therefore, we suggest that
PEP-1-rpS3 fusion protein has utility as a potential therapeutic
agent for skin diseases.PEP-1-rpS3
Control rpS3
His-Tag  – PEP-1  – rpS3
His-Tag  – rpS3
B
Fig. 1. The expression vector for PEP-1-rpS3 fusion protein. (A)
Construction of the PEP-1-rpS3 expression vector system based on the
vector pET-15b. Synthetic PEP-1 oligomer was cloned with into the
NdeI, XhoI sites, and human rpS3 cDNA was cloned into the XhoI,
BamHI sites of pET-15b. (B) Diagram of expressed control rpS3 and
PEP-1-rpS3 fusion proteins. The coding frame of human rpS3 is
represented by an open box along with 6His and the PEP-1 peptide.
The resulting vector was named pPEP-1-rpS3. Expression was induced
by adding IPTG.2. Materials and methods
2.1. Materials
Restriction endonuclease and T4 DNA ligase were purchased from
Promega Co. Oligonucleotides were synthesized from Gibco BRL cus-
tom primers. Ni2+-nitrilotri-acetic acid sepharose superﬂow was pur-
chased from Qiagen. Isopropyl-b-D-thiogalactoside (IPTG) was
obtained from Duchefa Co. Plasmid pET-15b and Escherichia coli
strain BL21 (DE3) were obtained from Novagen. A human ribosomal
protein S3 (rpS3) cDNA fragment was isolated using the polymerase
chain reaction (PCR) technique and a monoclonal antibody raised
against human rpS3 was produced in our laboratory [27].
2.2. Expression and puriﬁcation of PEP-1-rpS3
PEP-1-rpS3 expression vector was constructed to express the PEP-1
peptides (KETWWETWWTEWSQPKKKRKV) as a fusion with
human rpS3. Firstly, two oligonucleotides (top strand) 5 0-TATGA-
AAGAAACCTGGTGGGAAACCTGGTGGACCGAATGGTCTC-
AGCCGAAAAAAAAACGTAAAGTGC-3 0 and (bottom strand)
5 0-TCGABCACTTTACGTTTTTTTTTCGGCTGAGACCATTCG-
GTCCACCAGGTTTCCCACCAGGTTTCTTTCC-30 were synthe-
sized and annealed to generate a double-stranded oligonucleotide
encoding the PEP-1 peptides. The double-stranded oligo-nucleotide
was directly ligated into a NdeI–XhoI digested pET-15b vector. Next,
on the basis of the cDNA sequence of human rpS3, two primers were
synthesized. The sense primer, 5 0-CTCGAGATGGCAGTGCAAA-
TATCCAAGAAG-3 0 contains an XhoI site, and the antisense primer,
5 0-GGATCCTTATGCTGTGGGGACTGGCTGGGG-3 0, contains a
BamHI restriction site. The PCR was performed and the PCR product
was excised with XhoI and BamHI, eluted, ligated into a TA-cloning
vector and a pPEP-1 vector using T4 DNA ligase, and cloned in
E. coli DH5a cells. PEP-1-rpS3 fusion proteins were generated when
the human rpS3 gene was fused with a 21 amino acid PEP-1 peptide
in a bacterial expression vector in order to produce a genetic in-frame
PEP-1-rpS3 fusion protein (Fig. 1).
To produce the PEP-1-rpS3 fusion protein, the plasmid was trans-
formed into E. coli BL21 cells. The transformed bacterial cells were
grown in 100 ml of LB media at 37 C to a OD600 value of 0.5–1.0
and induced with 0.5 mM IPTG at 37 C for 3–4 h. Harvested cells
were lysed by sonication at 4 C in a binding buﬀer (5 mM imidazole,
500 mM NaCl, 20 mM Tris–HCl, pH 7.9), and the recombinant PEP-
1-rpS3 thus formed was puriﬁed. Brieﬂy, clariﬁed cell extracts were
loaded onto a Ni2+-nitrilotriacetic acid Sepharose aﬃnity columnunder native conditions. After the column was washed with 10 volumes
of a binding buﬀer and six volumes of a wash buﬀer (35 mM imidazole,
500 mM NaCl, and 20 mM Tris–HCl, pH 7.9), the fusion proteins
were eluted using an eluting buﬀer (0.5 M imidazole, 500 mM NaCl,
20 mM Tris–HCl, pH 7.9). The fusion protein containing fractions
was combined and the salts were removed using a PD-10 column.
The protein concentration was estimated by the Bradford procedure
using bovine serum albumin as a standard [28].
2.3. Transduction of PEP-1-rpS3 into human ﬁbroblast cells
The human skin ﬁbroblast cells were cultured in Dulbecco’s modi-
ﬁed Eagle’s medium containing 20 mM HEPES/NaOH (pH 7.4),
5 mM NaHCO3, 10% fetal bovine serum (FBS) and antibiotics
(100 lg/ml streptomycin, 100 U/ml penicillin) at 37 C under a humid-
iﬁed condition of 95% air and 5% CO2. For the transduction of PEP-1-
rpS3, skin cells were grown to conﬂuence on a 6-well plate. The culture
medium was then replaced with 1 ml of fresh solution. After skin cells
were treated with various concentrations of PEP-1-rpS3 for 1 h, the
cells were treated with trypsin–EDTA and washed with phosphate-buf-
fered saline (PBS). The cells were harvested for the preparation of cell
extracts to perform Western blot analysis.
The intracellular stability of transduced PEP-1-rpS3 fusion protein
was estimated as follows: after skin cells were treated with 3 lM native
PEP-1-rpS3 for 1 h, the cells were washed and changed with a fresh
culture medium to remove PEP-1-rpS3 that was not transduced. Cells
were then further incubated for 60 h, followed by preparations of cell
extracts for Western blot analysis. For Western blotting, proteins in
the cell extracts were separated on a SDS–PAGE and the proteins were
Fig. 2. Expression and puriﬁcation of PEP-1-rpS3 fusion protein.
Protein extracts of cells and puriﬁed fusion proteins were analyzed by
12% SDS–PAGE (A) and subjected to Western blot analysis with an
anti-rabbit polyhistidine antibody (B). Lanes in A and B are as follows:
lane 1, non-induced pPEP-1-rpS3; lane 2, induced pPEP-1-rpS3; lane
3, puriﬁed pPEP-1-rpS3.
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enhanced chemiluminescence (ECL) system.
2.4. Eﬀect of transduced PEP-1-rpS3 on cell viability
The biological activity of the transduced PEP-1-rpS3 fusion proteins
was assessed by measuring the cell viability of skin cells that were irra-
diated using a UV irradiator (Lilber Lourmat, France) emitting a
wavelength 312 nm for 1–2 min at dose 70 mJ/cm2. Following irradia-
tion, the cells were incubated for 24 h and then seeded into a 35 mm
dish at 70% conﬂuence. The cells were ﬁrst pre-treated with 3 lM
PEP-1-rpS3 for 3 h, followed by the UV radiation. Cell viability was
estimated with a colorimetric assay using 3-(4,5-dimethylthiazol-2-
yl)-2,5-dipheyltetrazolium bromide (MTT) staining.
2.5. Transduction of PEP-1-rpS3 into mice skin
To investigate the transductions of PEP-1-rpS3 fusion protein into
mice skin, male ICR mice weighing about 30 g were used. The animals
used in this experiment were treated according to the ‘Principles of
Laboratory Animal Care’ (NIH publication No. 86-23). Animals were
anesthetized with 3% isoﬂurance in nitrogen and oxygen, and 50 lg
PEP-1-rpS3 fusion proteins were topically applied to the shaved area
of the animal skin for various time intervals. Thereafter, frozen and
sectioned tissues were prepared and ﬁxed with 4% paraformaldehyde
for 10 min. For removal of non-speciﬁc immunoreactivity, free-ﬂoat-
ing sections were ﬁrst incubated with 0.3% Triton X-100 and 10% nor-
mal goat serum in PBS for 1 h at room temperature. They were then
incubated with rabbit antihistidine IgG (1:500) for 24 h at room tem-
perature. After washing three times for 10 min with PBS, the sections
were incubated for 1 h with biotinylated goat antirabbit IgG (dilution
1:200; Vector Laboratories, Burlingame, CA, USA), then visualized
with 3,3 0-diaminobenzidine (40 mg DAB/0.045% H2O2 in 100 ml
PBS) mounted on gelatin-coated slides. The immunoreactions were ob-
served under the Axioscope microscope (Carl Zeiss, Gottingen, Ger-
many).
2.6. Southwestern dot-blot analysis
Southwestern dot-blot analysis was performed according to the
method of Schwarz et al. [29]. Brieﬂy, genomic DNA was isolated from
106 cells according to the DNA extraction protocol from Biozym Diag-
nostik. Genomic DNA (2 lg) was transferred to a positively charged
nylon membrane by vacuum dot-blotting and ﬁxed by baking the
membrane for 15 min at 80 C. A monoclonal antibody directed
against thymine dimmers (Sigma, USA) was used for Southwestern
dot-blot analysis. Detection was carried out with a horseradish perox-
idase-conjugated anti-mouse antibody.
2.7. DNA fragmentation
DNA fragmentation was performed according to the method of
Iwahashi et al. [30]. Brieﬂy, cultured cells were lysed and treated with
RNase and proteinase K. The DNA was then extracted with phenol–
chloroform, precipitated with isopropanol, washed with ethanol, and
air-dried. DNA samples were separated by 1.5% agarose gel electro-
phoresis and visualized under UV light.3. Results
3.1. Construction and puriﬁcation of PEP-1-rpS3
fusion protein
To generate a cell-permeable expression vector, PEP-1-rpS3
vector, a human rpS3 cDNA was subcloned into the pET-15b
plasmid that had been reconstructed to contain the PEP-1 pep-
tide. The PEP-1-rpS3 expression vector thus formed contained
consecutive cDNA sequences encoding human rpS3, PEP-1
peptide (21 amino acids) and six histidine residues at the ami-
no-terminus (Fig. 1). We also constructed the SOD expression
vector to produce control rpS3 protein without PEP-1 trans-
duction peptides (data not shown).
Following the induction of expression, the PEP-1-rpS3 and
control rpS3 fusion proteins were puriﬁed. Brieﬂy, the fusionproteins were expressed in E. coli and the clariﬁed cell extracts
were loaded onto a Ni2+-nitrilotriacetic acid Sepharose aﬃnity
column under native conditions. Fusion protein containing
fractions was combined and salts were removed using a
PD10 column. The crude cell extracts obtained from E. coli
and puriﬁed PEP-1-rpS3 fusion proteins were electrophoresed
in 12% SDS–PAGE. The expression and puriﬁcation results
are shown in Fig. 2A. The bands in lanes 2 and 3 show that
the protein was highly expressed, and was a major component
of the total soluble proteins. The expressed and puriﬁed pro-
teins were further conﬁrmed by Western blot analysis using
an anti-rabbit polyhistidine antibody. PEP-1-rpS3 was de-
tected at the corresponding bands in Fig. 2B. The rpS3 without
PEP-1 as a control was expressed and puriﬁed as described
previously (data not shown) [27].3.2. Transduction of PEP-1-rpS3 fusion protein into human
ﬁbroblast cells
The intracellular delivery of PEP-1-rpS3 into ﬁbroblast cells
was conﬁrmed by direct ﬂuorescence analysis. As shown in
Fig. 3, the cultured cells were found to be transduced with
PEP-1-rpS3. To exclude the possibility that cell ﬁxation with
paraformaldehyde may aﬀect PEP-1-rpS3 transduction by di-
rect ﬂuorescence, we used FITC conjugated PEP-1-rpS3 fusion
protein to transduce into non-ﬁxed or ﬁxed ﬁbroblast cells.
The intracellular distribution of the PEP-1-rpS3 ﬂuorescence
signal of non-ﬁxed cells was similar to that of ﬁxed cells
(Fig. 3). However, only faint ﬂuorescence signals were detected
in cells treated with control rpS3 and this ﬂuorescence was sim-
ilar to that of background. To clarify further the subcellular
localization of transduced proteins in the cells, nuclear and
cytosolic fractions were prepared from cells transduced with
PEP-1-rpS3 and analyzed by Western blotting using anti-
rpS3, anti-actin and anti-PARP antibodies. PEP-1-rpS3 fusion
proteins were detected predominantly localized into the cyto-
plasm than into the nucleus, whereas control rpS3 was not de-
tected in the cells (data not shown). These results indicate that
cell ﬁxation with paraformaldehyde is not required for PEP-1-
rpS3 fusion protein transduction.
Fig. 3. Cellular localization of PEP-1-rpS3 fusion protein. Localization of transduced PEP-1-rpS3 fusion proteins when the skin cells were ﬁxed or
non-ﬁxed with paraformaldehyde. Skin cells were treated with FITC-labeled PEP-1-rpS3 (3 lM) fusion proteins for 60 min, and then the cells were
incubated with anti-rabbit polyhistidine (1:400) for 1 h. The cells were washed twice with trypsin–EDTA, PBS and immediately observed by
ﬂuorescence microscopy. Negative control cells only (A), positive control cells treated with rpS3 (B), non-ﬁxed cells treated with PEP-1-rpS3 (C), and
ﬁxed cells treated with PEP-1-rpS3 (D).
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protein, we analyzed the transduction of PEP-1-rpS3 proteins
by adding them to ﬁbroblast culture media at 3 lM for various
times (15–120 min), and then analyzed the transduced protein
levels by Western blotting. The intracellular concentration of
transduced PEP-1-rpS3 in cells was detected within 15 min
and was seen to gradually increase at 120 min (Fig. 4A). The
dose-dependency of the transduction of PEP-1-rpS3 fusionFig. 4. Transduction of PEP-1-rpS3 fusion proteins. (A) 3 lM PEP-1-
rpS3 and control rpS3 were added to the culture media for 15–120 min,
(B) 0.25–3 lM of PEP-1-rpS3 and control rpS3 were added to the
culture media for 1 h, (C) cells pre-treated with 3 lM PEP-1-rpS3
incubated for 1–60 h, and analyzed by Western blot analysis.proteins was further analyzed. Various concentrations (0.25–
3 lM) of PEP-1-rpS3 proteins were added to ﬁbroblast in cul-
ture for 60 min, and the levels of transduced proteins were
measured by Western blotting. As shown in Fig. 4B, the levels
of transduced proteins in ﬁbroblast cells were concentration-
dependently increased on increasing the amount of fusion pro-
tein in culture media. These results indicated that PEP-1-rpS3
fusion proteins eﬃciently trasnduced into ﬁbroblast cells in a
time- and concentration-dependent manner. However did not
show in case of the control rpS3.
The intracellular stability of transduced PEP-1-rpS3 into
ﬁbroblast cells is shown in Fig. 4C. The PEP-1-rpS3 protein
was added to the culture media of ﬁbroblast cells at a concen-
tration 3 lM for various time periods and the resulting levels
of transduced protein were analyzed by Western blotting.
The intracellular level of transduced PEP-1-rpS3 into cells
was initially detected after 1 h, and then declined gradually
over the period of observation. However, signiﬁcant levels of
transduced rpS3 protein persisted in ﬁbroblast cells for 48 h
(Fig. 4C).
3.3. Penetration of PEP-1-rpS3 fusion protein into mice skin
We then evaluated the ability of PEP-1-rpS3 fusion protein
to transduce into mouse skin. It was sprayed onto mouse skin
at a concentration 3 lM for 1 h, and the degrees of penetration
of these fusion proteins were analyzed immunohistochemi-
cally. As shown in Fig. 5, signiﬁcant transduction signals were
detected in the epidermis and dermis of skins treated with PEP-
1-rpS3 fusion proteins. These results demonstrate that PEP-1-
rpS3 fusion protein can not only be transduced into cultured
ﬁbroblast cells but also penetrate living animal skin.
Fig. 5. Histochemical analysis of animal skin transduced with PEP-1-rpS3 fusion protein. Fifty lg of PEP-1-rpS3 fusion proteins was topically
applied onto the shaved area of mouse dorsal skin for 60 min. Frozen sections of skin tissues were immunostained with rabbit anti-histidine IgG
(1:400) and then stained with biotinylated goat anti-rabbit IgG (1:200). The sections were visualized with 3,3 0-diaminobenzidine and observed under
an Axioscope microscope.
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viability of cells under UV radiation
To determine whether the transduced fusion protein has a
functional role in cells, we tested the eﬀects of transduced
fusion proteins on cell viability under UV-irradiation induced
cell death. The viability of cells exposed to UV irradiation was
signiﬁcantly increased in a dose-dependent manner when
pre-treated with PEP-1-rpS3. As shown in Fig. 6, when the
cells were exposed to UV irradiation without PEP-1-rpS3
and, only 40–45% of cells were viable. However, the viability
of the cells pretreated with PEP-1-rpS3 increased in a dose-
dependent manner, reaching over 80% at the maximum con-
centration used, whereas control rpS3 failed to protect against
cell death. The increased viability of cells transduced with
PEP-1-rpS3 suggests that this fusion protein has a critical pro-
tective eﬀect on cells against UV irradiation.
3.5. Transduced PEP-1-rpS3 fusion protein protect
UV-induced DNA damage
As the severity of DNA damage is one of the major
determinants for cell death upon UV exposure, the eﬀect of
PEP-1-rpS3 on the UV-speciﬁc DNA lesions was determined.Fig. 6. Eﬀect of transduced PEP-1-rpS3 on cell viability of skin cells.
UV exposed skin cells pre-treated with 1–5 lM PEP-1-rpS3 and
control rpS3 for 1 h. Cell viabilities were estimated by with a
colorimetric assay using MTT. Each bar represents the mean ± S.E.M.
obtained from ﬁve experiments. Asterisks and crosses denote statistical
signiﬁcance at P < 0.05 and P < 0.01, respectively. The statistical
analysis was evaluated by Student’s t-test.Southwestern dot-blot analysis using an antibody directed
against cyclobutane pyrimidine dimmers revealed that inFig. 7. Transduced PEP-1-rpS3 fusion protein inhibits UV-induced
DNA damage. Skin cells were exposed to UV in the absence or
presence of 3 lM PEP-1-rpS3 and control rpS3. After UV exposure,
(A) DNA was extracted and analysis performed by southwestern dot-
blot using an antibody against cyclobutane pyrimidine dimmers. (B)
DNA fragmentation was analyzed by agarose gel electrophoresis. M
represents DNA molecular weight marker (100 bp DNA ladder).
Lanes are as follows: lane 1, control cellls; lane 2, UV-exposed cells;
lane 3, rpS3 treated cells; lane 4, PEP-1-rpS3 treated cells.
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age was signiﬁcantly increased. However, transduced PEP-1-
rpS3 fusion protein, time- and dose-dependently, eﬃciently
protects against UV-induced DNA damage (Fig. 7A).
Furthermore, we performed DNA fragmentation analysis in
order to measure the UV damage and protective eﬀect by PEP-
1-rpS3. As shown in Fig. 7B, DNA fragmentation was induced
excessively in cells exposed to UV. DNA fragmentation was
signiﬁcantly decreased by PEP-1-rpS3 fusion protein transduc-
tion. However, control rpS3 did not protect against UV-in-
duced DNA damage. These results indicate that transduced
PEP-1-rpS3 plays a defensive role in cells under UV exposure
by inducing damaged DNA repair.4. Discussion
It is well known that ribosomal proteins are the major
component of ribosome. These proteins are synthesized in
the cytoplasm and transferred to the nucleus. In the nucleus,
the ribosomal proteins assemble with processed rRNA and
form two ribosomal subunits, 40S or 60S. These are exported
to cytoplasm and participate in protein synthesis [31].
Recently, ribosomal protein function is reported to have activ-
ity related to DNA repair processing and UV endonuclease
activity [10,32]. These activities imply that rpS3 may be in-
volved in the DNA repair process. Since the multifunctional
activity of rpS3 protein, various human diseases including skin
cancer are related to this protein.
Although rpS3 has been considered potential as a therapeu-
tic protein against UV damage, its inability to enter cells
hinders its use for this purpose. Therefore, in an eﬀort to deli-
ver rpS3 protein to cells and tissues, we investigated the possi-
bility of a protein transduction. Recently, the Morris group
designed a 21-residue peptide carrier, PEP-1 (KETWWETW-
WTEWSQPKKKRKV), which consists of three domains: a
hydrophobic tryptophan rich motif (KETWWETWWTEW),
a spacer (SQP), and a hydrophilic lysine-rich domain
(KKKRKV). The hydrophobic domain is required for eﬃ-
ciently targeting the cell membrane and for hydrophobic inter-
actions with proteins, whereas the hydrophilic domain is
required to improve intracellular delivery. When mixed PEP-
1 peptide and target protein (GFP, b-gal) were overlaid on cul-
tured cells, it was found that the non-denatured target protein
was transduced [33]. In previous studies, we showed that PEP-
1-SOD fusion protein was eﬃciently transduced into cells and
skin tissue. Moreover, transduced PEP-1-SOD proved enzy-
matically and biologically active, and eﬃciently protected
against neuronal cell death caused by transient forebrain ische-
mia [34]. More recently, we reported that PEP-1-SOD fusion
protein can be directly transduced into neuronal cells across
the blood–brain barrier and it can eﬃciently protect against
paraquat-induced Parkinson’s disease in the mouse model [35].
To develop an expression system capable of overexpressing
the cell-permeable rpS3 protein, the human rpS3 gene was
fused with a PEP-1 peptide in a bacterial expression vector
to produce a genetic in-frame PEP-1-rpS3 fusion protein
(Fig. 1). The PEP-1-rpS3 fusion protein was highly expressed
as a major component of the total soluble proteins in cells
and it was found to be nearly homogeneous and greater than
95% pure, as determined by a SDS–PAGE analysis. The
expressed and puriﬁed PEP-1-rpS3 fusion proteins were con-ﬁrmed by Western blot using a monoclonal antibody to a
human rpS3 and an anti-rabbit polyhistidine antibody.
Puriﬁed PEP-1-rpS3 fusion proteins were eﬃciently trans-
duced into cells in a time- and dose-dependent manner.
Although the mechanism of transduction is unclear, Tat
PTD fusion protein transduction is one of the developments
in protein therapeutics. A wide variety of functional proteins
have been successfully used to study intracellular function
and transduction into cells and tissues [17]. It has been
reported that cell incubation with various PTD results in their
rapid uptake with a predominantly nuclear localization and
lack of the punctate cytoplasmic labeling characteristic of
endocytic uptake [38]. However, in this study, PEP-1-rpS3
transduced into ﬁbroblast cells within one hour and it was
predominantly localized into the cytoplasmic compartment.
Vazquez et al. demonstrated that speciﬁc localization of trans-
duced protein is relevant issues that are easily resolved by
mutation of the nuclear localization signal of PTD, which
would result in its exclusion from the nucleus and accumula-
tion in the cytoplasmic compartment only [36]. Therefore, we
can assumed that the transduction of protein fused with
PEP-1 vector might be localized in the cytosol, whereas the
Tat-fused protein usually transduces into the nucleus. PTD
fusion protein transduction has been questioned because it is
caused by an artifactual redistribution caused by cell ﬁxation
[37,38]. Thus, it was argued that cell ﬁxation should be avoided
in studies of protein transduction into living cells. However, in
this study, we were unable to detect diﬀerences in the ﬂuores-
cence distribution of transduced PEP-1-rpS3 in non-ﬁxed and
ﬁxed cells. These results demonstrate that cell ﬁxation with
paraformaldehyde is not required for PEP-1-rpS3 transduc-
tion. Similar observations have been reported which indicate
that artifacts of protein transduction are not induced by para-
formaldehyde ﬁxation [39,40]. We also observed that the trans-
duction of PEP-1-SOD fusion protein into neuronal cells was
not aﬀected by paraformaldehyde ﬁxation [34].
The intracellular stability of transduced PEP-1-rpS3 was sig-
niﬁcant with transduced protein persisting in cells for 48 h
(Fig. 4C). We then examined the ability of PEP-1-rpS3 fusion
protein to transduce into mouse skin and showed that this
could be done successfully (Fig. 5). Those results demonstrate
that PEP-1-rpS3 can be transduced eﬃciently into mammalian
cells and tissues such as skin, which therefore oﬀers potential
as a therapeutic agent against skin disorders mediated by
UV. A recent study by Morris et al. showed that PEP-1
peptide/GFP (green ﬂuorescent protein, 30 kDa) or b-Gal
(b-galactosidase, 119 kDa) mixtures transduce into a human
ﬁbroblast cell line (HS-68) and into Cos-7 cells by incubating
with PEP-1 peptide carrier and proteins (GFP or b-gal) for
30 min at 37 C [33]. These diﬀerences in the time courses of
transduction may depend on whether the target protein is
fused with the PEP-1 vector or mixed with the PEP-1 peptide.
Because of fusion with the PEP-1 vector, the conformation,
polarity, and the molecular shape of a target protein might
be altered, which improves the transduction of fusion proteins
into cells. Our previous studies showed that the transduced
PEP-1-SOD and Tat-SOD into neuronal cells across the
blood–brain barrier and showed that it protected against ische-
mic insults [26,34]. SOD fusion proteins eﬃciently transduced
into cells and tissues. The enzyme activities of transduced PEP-
1-SOD in cells and mice skin are signiﬁcantly increased and
higher than those of Tat-SOD. In addition, PEP-1-SOD fusion
S.H. Choi et al. / FEBS Letters 580 (2006) 6755–6762 6761protein more eﬃciently protected against neuronal cell death
than Tat-SOD. These diﬀerences in enzymatic activities of
these fusion proteins imply that denatured Tat-SOD is needed
for refolding after transduction, whereas PEP-1-SOD does not
for refolding after transduction. Also, Morries et al. reported
that the PEP-1 peptide carrier presents several advantages
for protein therapy, including the translocation of native pro-
tein, a high stability, a lack of toxicity, and a lack of sensitivity
to serum. In particular, no toxicity to PEP-1 peptide was
observed in several cell lines at up to 0.1–1 mM, while cell
viability was decreased by only about 10% for PEP-1 concen-
tration of 1 mM [33].
To determine whether transduced PEP-1-rpS3 can play its
biological role in cells, we tested the eﬀect of transduced
PEP-1-rpS3 on cell viability under UV exposure. The viability
of UV exposed cells was signiﬁcantly increased when cells were
pre-treated with PEP-1-rpS3 fusion proteins in a dose-depen-
dent manner (Fig. 6). After the cells were exposed to UV
irradiation without PEP-1-rpS3, only 40–45% of the skin cells
were viable. However, transduced PEP-1-rpS3 protected
against cell death by over 80%. Those results indicate that
transduction of PEP-1-rpS3 was deﬁnitely eﬀective against
UV-induced skin cell death.
Next, we examined the ability of transduced PEP-1-rpS3
fusion protein inhibiting UV-induced DNA damage, cyclobu-
tane pyrimidine dimmer and DNA fragmentation. As shown
in Fig. 7, transduced PEP-1-rpS3 fusion protein eﬃciently pro-
tects against UV-induced DNA damage. It is well known that
UV irradiation is one of the typical DNA damaging agents and
can induce DNA strand breaks, photoproducts formation, and
pyrimidine dimmer formation. These DNA damages trigger a
cell death mechanism and induce apoptosis. Moreover, UV-in-
duced apoptosis may have a profound impact on the induction
of mutations and skin cancer [41]. Therefore, transduced PEP-
1-rpS3 plays a defensive role in cells under UV exposure by
inducing damaged DNA repair.
In summary, we demonstrate for the ﬁrst time that human
rpS3 fused with PEP-1 peptide (PEP-1-rpS3) can be eﬃciently
transduced in vivo and in vitro in its native conformation.
Moreover, transduced PEP-1-rpS3 is biologically active in
cells. In addition, PEP-1-rpS3 signiﬁcantly protects against
UV-induced skin cell death. Our success on the protein trans-
duction of PEP-1-rpS3 may provide a new strategy for protect-
ing skin cell death resulting from UV-induced DNA damage
and, therefore, may provide an opportunity for therapeutic
intervention using rpS3 for the treatment of UV-induced skin
diseases such as skin cancer or aging.
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